Hospital-Acquired Infection Control Market Outlook 2036: North America Dominates as 3M, STERIS, and Getinge AB

According to the latest market analysis by Future Market Insights, the global Hospital-Acquired Infection (HAI) Control Market is witnessing strong growth driven by increasing hospital investments in infection prevention infrastructure, rising regulatory mandates for infection surveillance, growing adoption of sterilization and disinfection technologies, and the expanding clinical burden of healthcare-associated infections across hospital systems worldwide.

Market analysis indicates the Hospital-Acquired Infection (HAI) Control Market was valued at USD 7.44 billion in 2025 and is projected to reach approximately USD 7.95 billion in 2026 before expanding to USD 15.34 billion by 2036, reflecting a CAGR of 6.8% during the 2026-2036 forecast period.

The industry is expected to create an incremental opportunity of approximately USD 7.40 billion over the next decade, supported by rising procurement of disinfectants, sterilization systems, personal protective equipment (PPE), environmental monitoring solutions, and infection prevention services across healthcare environments.

Quick Stats: Hospital-Acquired Infection (HAI) Control Market

• Market Value (2025): USD 7.44 Billion
• Estimated Market Size (2026): USD 7.95 Billion
• Forecast Market Value (2036): USD 15.34 Billion
• CAGR (2026-2036): 6.8%
• Incremental Opportunity: USD 7.40 Billion
• Leading Component Segment: Consumables (46.9% share in 2026)
• Leading Infection Control Practice: Hand Hygiene Management (38.6% share in 2026)
• Leading Technology Segment: Sterilization Technology (41.2% share in 2026)
• Major End-use Industries: Hospitals, ICUs, Ambulatory Surgical Centers
• Fastest Growing Markets: USA and South Korea
• Key Growth Drivers: Infection Prevention Regulations, Sterilization

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-16573

Regulatory Compliance and Infection Prevention Programs Drive Procurement Growth

The growing global focus on healthcare quality standards and infection prevention compliance continues to accelerate demand for HAI control products and services.

Healthcare regulators and accreditation bodies increasingly require hospitals to implement infection surveillance programs, sterilization validation procedures, and hand hygiene compliance monitoring systems.

Hospitals are also expanding infection control budgets to reduce the incidence of surgical site infections, bloodstream infections, ventilator-associated pneumonia, urinary tract infections, and gastrointestinal infections that increase treatment costs and patient hospitalization periods.

Consumables Segment Maintains Market Leadership

Consumables are expected to account for 46.9% of the component segment in 2026, reflecting continuous purchasing demand for disinfectants, sterilization consumables, waste disposal products, gloves, masks, gowns, and surface cleaning chemicals.

The recurring nature of consumable procurement makes this segment one of the most stable revenue generators within the HAI control industry. Hospitals continue prioritizing long-term procurement agreements to ensure uninterrupted availability of infection prevention supplies across intensive care units, operating rooms, and emergency care facilities.

Hand hygiene management is projected to hold 38.6% of the infection control practice segment in 2026, supported by strong clinical evidence linking hand hygiene compliance with reduced HAI incidence.

Sterilization Technology Upgrades Accelerate Capital Investments

Sterilization technology is expected to account for 41.2% of the technology segment in 2026 as healthcare systems increasingly modernize infection prevention infrastructure.

Hospitals are adopting advanced sterilization and disinfection technologies including UV-C disinfection systems, hydrogen peroxide vapor systems, automated room disinfection robots, and low-temperature sterilization equipment to supplement traditional cleaning protocols.

The emergence of antimicrobial-resistant organisms such as MRSA and C. difficile is also increasing the urgency for hospitals to deploy advanced infection prevention technologies.

Hospitals and Intensive Care Units Remain Primary End Users

Hospitals and intensive care units are expected to account for 58.7% of end-user demand due to the high infection exposure risk associated with surgical procedures, invasive devices, and critical care treatment environments.

Large hospital systems continue investing heavily in infection prevention programs to improve patient safety metrics and meet regulatory compliance standards.

Ambulatory surgical centers and diagnostic facilities are also increasing procurement of sterilization and disinfection solutions as outpatient care volumes continue expanding globally.

Customize insights for your business strategy: https://www.futuremarketinsights.com/customization-available/rep-gb-16573

Regional Outlook: USA and South Korea Lead Market Expansion

United States
The United States remains one of the leading markets for HAI control solutions and is projected to grow at a CAGR of 6.9% through 2036.
Growth is supported by the country's extensive hospital infrastructure, stringent infection control regulations, and rising investments in hospital surveillance systems and sterilization technologies.

South Korea
South Korea is projected to grow at a CAGR of 6.9% through 2036, supported by healthcare quality accreditation programs, hospital modernization initiatives, and increasing investments in advanced medical infrastructure.

Europe and Japan
European markets continue demonstrating stable growth due to harmonized healthcare quality regulations and strict infection prevention standards. Meanwhile, Japan continues benefiting from advanced hospital hygiene infrastructure and high healthcare compliance standards.

Competitive Landscape Focuses on Product Portfolio and Compliance Expertise

The Hospital-Acquired Infection (HAI) Control Market remains highly competitive, with companies competing across product portfolio breadth, sterilization technology expertise, regulatory compliance capabilities, and service network strength.

Key industry participants include:

• Olympus Corporation
• BD
• Getinge AB
• Steris Corporation
• 3M
• Ecolab Inc.
• Xenex Disinfection Services Inc.

In 2025, BD launched the BD SurgiphorTM Surgical Wound Irrigation System in Europe to support surgical site infection reduction initiatives.

Outlook Through 2036

The Hospital-Acquired Infection (HAI) Control Market is expected to maintain strong long-term growth as healthcare systems continue prioritizing infection prevention, regulatory compliance, and patient safety improvements.

Future market expansion is expected to be supported by:

• Rising infection surveillance requirements
• Increasing hospital sterilization investments
• Growing adoption of UV-C and hydrogen peroxide disinfection technologies
• Expanding PPE and disinfectant procurement
• Growing antimicrobial resistance concerns
• Healthcare accreditation and compliance mandates
• Rising outpatient surgical procedure volumes

Purchase Full Report for Detailed Insights: https://www.futuremarketinsights.com/reports/hospital-acquired-infection-control-market

Why FMI: https://www.futuremarketinsights.com/why-fmi

Explore More Related Studies Published by FMI Research:

Bioplastic and Biopolymer Market: https://www.futuremarketinsights.com/reports/bioplastic-and-biopolymer-market

Hexagonal boron nitride powder (h-BN) Market: https://www.futuremarketinsights.com/reports/hexagonal-boron-nitride-powder-market

Helium Gas Market: https://www.futuremarketinsights.com/reports/helium-gas-market

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

About Future Market Insights (FMI)

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.

This release was published on openPR.